Literature DB >> 1646237

In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo.

K Cooper1, C S Herrington, A K Graham, M F Evans, J O McGee.   

Abstract

In South Africa asymptomatic wart virus infection diagnosed by morphological criteria occurs in 16-20% of all ethnic groups; the incidence in black women is 66%. To identify human papillomavirus (HPV) types the prevalence of HPV in cervical intraepithelial neoplasia (CIN) in South African women (n = 72) with age matched British women (n = 73) was compared by non-isotopic in situ hybridisation (NISH) using digoxigenin labelled probes for HPV 6, 11, 16, 18, 31, 33 and 35 on archival biopsy specimens. A higher proportion of British biopsy specimens (68%) contained HPV than those from South Africa (50%) in CIN 2 and 3; this difference was due to HPV 16. Thirty six per cent of the positive biopsy specimens from South African women also contained HPV 33/35 compared with 16% in the United Kingdom. There was no difference in HPV detection with age in either group. These data indicate that HPV types vary geographically, with "minor" HPV types being more common in South Africa. Three qualitatively distinct NISH signals were observed; a diffuse (type 1) signal in superficial cells, mainly koilocytes; a punctate signal (type 2) in basal/"undifferentiated" cells in CIN 3; and combined type 1 and 2 signals in CIN with wart virus infection (type 3). The punctate signal may represent HPV integration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646237      PMCID: PMC496872          DOI: 10.1136/jcp.44.5.400

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Simultaneous in situ genotyping and phenotyping of human papillomavirus cervical lesions: comparative sensitivity and specificity.

Authors:  A K Graham; C S Herrington; O McGee J
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

2.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization.

Authors:  A Mincheva; L Gissmann; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer.

Authors:  S T Cole; R E Streeck
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

4.  Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.

Authors:  P G Toon; J R Arrand; L P Wilson; D S Sharp
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-15

5.  Human papillomaviruses of different types in precancerous lesions of the uterine cervix: histologic, immunocytochemical and ultrastructural studies.

Authors:  A S Kadish; R D Burk; Y Kress; S Calderin; S L Romney
Journal:  Hum Pathol       Date:  1986-04       Impact factor: 3.466

6.  Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long-term prospective follow-up.

Authors:  K Syrjänen; R Mäntyjärvi; S Saarikoski; M Väyrynen; S Syrjänen; S Parkkinen; M Yliskoski; J Saastamoinen; O Castren
Journal:  Br J Obstet Gynaecol       Date:  1988-11

7.  HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia.

Authors:  C A Meanwell; M F Cox; G Blackledge; N J Maitland
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

8.  Detection of human papillomavirus DNA sequences by in situ DNA-DNA hybridisation in cervical intraepithelial neoplasia and invasive carcinoma: a retrospective study.

Authors:  J E Collins; D Jenkins; D J McCance
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

9.  Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion.

Authors:  F G Rathjen; M Schachner
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

Review 10.  Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence.

Authors:  N Muñoz; X Bosch; J M Kaldor
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

View more
  24 in total

1.  The incidence of HPV in a Swedish series of invasive cervical carcinoma.

Authors:  B Hagmar; B Johansson; M Kalantari; Z Petersson; B Skyldberg; L Walaas
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  HPV genotypes in cervical neoplasia in South Africa.

Authors:  K Cooper; J O McGee
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

3.  In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa.

Authors:  K Cooper; C S Herrington; A K Graham; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

4.  Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.

Authors:  K Cooper; C S Herrington; J E Stickland; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

5.  Human papillomavirus and schistosomiasis associated bladder cancer.

Authors:  K Cooper; Z Haffajee; L Taylor
Journal:  Mol Pathol       Date:  1997-06

6.  Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.

Authors:  M A Ozbun; C Meyers
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

7.  Comparative analysis of human papillomavirus detection by dot blot hybridisation and non-isotopic in situ hybridisation.

Authors:  G Troncone; S M Anderson; C S Herrington; M L de Angelis; H Noell; J A Chimera; J O'D McGee
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

8.  Detection of human papillomavirus infection by non-isotopic in situ hybridisation in condylomatous and CIN lesions.

Authors:  R Pöllänen; S Vuopala; V P Lehto
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

9.  Sequence variation in the L1 gene of human papillomavirus type 16 from Africa.

Authors:  J E Ramesar; E P Rybicki; A L Williamson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea.

Authors:  Benjamín García-Espinosa; Ma Paz Nieto-Bona; Sonsoles Rueda; Luís Fernando Silva-Sánchez; Ma Concepción Piernas-Morales; Patricia Carro-Campos; Luís Cortés-Lambea; Ernesto Moro-Rodríguez
Journal:  Diagn Pathol       Date:  2009-09-09       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.